Robertet acquires Phasex to expand its extraction capabilities
The supplier of natural ingredients for flavors and fragrances has signed an agreement to acquire Phasex, a pioneer in supercritical CO2 extraction, headquartered in North Andover, Massachusetts, USA.
Founded in 1981, Phasex focuses on three market segments: natural products, biopharmaceuticals and polymers.
Supercritical CO2 extraction technology enables the extraction of aromatic or functional ingredients from solid biomass or liquid feedstocks using supercritical carbon dioxide. Supercritical CO2 is more environmentally friendly than existing alternatives such as hexane, butane and ethanol. The supercritical process requires the use of pressure and temperature to reach the supercritical phase, where CO2 is between liquid and gas. In this phase, CO2 has a unique solubility ability and can therefore remove certain components from the matrix material.
Phasex has been at the forefront of this technology since its inception, from R&D and pilot to large-scale production. The company has 30 employees and has annual sales of between €5 million and €12 million ($5.44 million to $13.06 million) over the past five years. Robertet said he wants to double the company's revenues in the coming years, particularly by developing a new range of natural ingredients for flavors and fragrances.
The acquisition of a supplier that Robertet has been working closely with since 2018 will help the company strengthen its production capabilities and expand CO2 extraction capabilities to North American customers.
"The acquisition of Phasex is an important step forward for us. Robertet is now the first company in the flavors and fragrances industry to invest in CO2 extraction in North America, with a focus on high added value extracts for the flavor and nutricosmetics industries. By integrating Phasex's expertise, we will further consolidate our leading position in natural ingredients while developing more sustainable and efficient solutions for our customers. With this transaction, we strengthen our industrial base in North America, which is one of the key drivers to achieve our goal of reaching €1 billion in total sales by 2030," said Jérôme Bruhat, CEO of the Robertet Group.
2026-08-15
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
DSM-Firmenich sells majority of ROBERTET shares
-
Robertet partners with Aethera to strengthen its active ingredients offering
-
Global Biologicals M&A Storm: How 2025 Redrew the Agricultural Innovation Map
-
ADNOC Reroutes Naphtha via Oman to Bypass Hormuz Risk
-
US MDI Supply Squeeze Triggers Price Hikes
-
Uzbekistan Bets $17 Billion on Chemical Industry Upgrade
-
Fertilizer Shock Reshapes Rice Export Decisions
-
“Changing the Captain at Sea”: Hempel’s CEO Departs to Run a Ferry Giant—This Isn’t a Resignation Notice, It’s an Industry Stress Map
-
The Chemical Market Is No Longer Just Raising Prices — It Has Started Stopping Quotations
-
March Brought a Faster Global Food Rule Cycle
Recommend Reading
-
Brazil Rewrites the Supplement Rulebook
-
Selling the Family Silver for a New Suit? Why Bohai Chemical’s Transformation Drama Got Canceled After Just Two Acts
-
China Moves Lycopene Toward Filing-Based Health Food Management
-
India’s Tariff Cuts Could Lower Agrochemical Costs
-
Lupin Secures Tentative U.S. Approval for Its Multiple Sclerosis Tablet
-
FSANZ Moves Toward Approval of Insect-Resistant Corn COR121
-
In mid-December, the price of 180CST fuel oil in China first rose and then fell
-
Thymol Gel Wins EPA Approval for Beekeepers
-
FDA Orders Removal of “Suicidality Warning”: Are Weight-Loss Blockbusters Finally Cleared—or Is Regulators Giving the Market a Reality Check?
-
Moving Average Crossover, June Isooctanol Prices in China Rise